The Pharmaceutical Journal
Vol 276 No 7389 p223
25 February 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Switch data exclusivity guidance

Guidelines (PDF 50K) on how pharmaceutical companies can claim a year's data exclusivity on reclassifications of medicines from prescription-only to over-the-counter status have been published by the European Commission. Exclusivity would be granted on the basis of significant pre-clinical or clinical trials.